Foreign Product Alert: Body Con Plus capsules, Physic Candy - Define, 7-Day Slim Extreme capsules

Starting date:
October 27, 2017
Type of communication:
Foreign Product Alert (FPA)
Subcategory:
Natural health products
Source of recall:
Health Canada
Identification number:
RA-64984

Issue

These foreign health products have been found by regulators in other countries to contain undeclared drug ingredients.

The products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.

Unauthorized Foreign Health Products
Product Name(s) Hazard(s) Identified Source of Alert Images
Unauthorized Weight Loss Products
Body Con Plus capsules Undeclared sibutramine and phenolphthalein Australia Therapeutic Goods Administration Unauthorized weight loss product - Body Con Plus capsules
Physic Candy - Define Undeclared sibutramine United States Food and Drug Administration Unauthorized weight loss product - Physic Candy - Define
7-Day Slim Extreme capsules Undeclared sibutramine Australia Therapeutic Goods Administration Unauthorized weight loss product - 7-Day Slim Extreme capsules

 

What you should do

  • Contact Health Canada at 1-800-267-9675 or by completing an online complaint form if you find a product listed above in the Canadian marketplace.

  • Consult a healthcare professional if you have health concerns related to the use of any of these products.

  • Read the label of the products you buy to verify that they have been assessed by Health Canada for safety, effectiveness and quality. Health products that have been authorized for sale by Health Canada will have an eight-digit Drug Identification Number (DIN), Natural Product Number (NPN) or Homeopathic Drug Number (DIN-HM).

Background

Prescription drugs should only be used under the supervision of a healthcare professional.

Phenolphthalein was previously used as a laxative, but is no longer authorized for sale in Canada because it may cause cancer. Additional side effects include decreased blood pressure, skin rash, and gastrointestinal bleeding.

Sibutramine was previously used to treat obesity but is no longer authorized for sale in Canada because of its association with an increased risk of cardiovascular side effects such as heart attack and stroke. Other side effects include increased blood pressure and heart rate, dry mouth, difficulty sleeping, and constipation.

Report health or safety concerns

To report a side effect for a health product to Health Canada:

  • call toll-free at 1-866-234-2345; or
  • visit Health Canada's webpage on Adverse Reaction Reporting for information on how to report online, by mail, or by fax.

As of October 12, 2017, no adverse reactions suspected to be associated with the use of these products have been reported to Health Canada.

Images

Select thumbnail to enlarge - opens in a new window